Alkermes, Inc. (NASDAQ:ALKS)
CAPS Rating:
A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.
A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.
Recs
Almost got the top on this one.